SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort
Zoé L. E. van Kempen, Eva Strijbis, Marissa M. C. T. Al, Maurice Steenhuis, Bernard M.J. Uitdehaag, Theo Rispens, Joep Killestein
Abstract
Various cohorts of patients with multiple sclerosis (MS) and COVID-19 have been described. So far, limited information is available regarding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in patients with MS. The objective of this study was to test for SARS-CoV-2 antibodies in a large MS cohort to evaluate asymptomatic infections and immunological responses to COVID-19.
Topics & Concepts
Multiple sclerosisAsymptomaticCohortMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)AntibodyCohort study2019-20 coronavirus outbreakVirologyImmunologyInternal medicineDiseaseInfectious disease (medical specialty)OutbreakSARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders